chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Food poisoning, Headache, Myalgia, Pain in extremity
Clinical narrative: She thought maybe she had food poisoning bc of the weird symptoms; headache; achy muscles; loose stools; sore arm; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), on 20Dec2020 at single dose for covid-19 immunisation. Medical history included None. There were no concomitant medications. The patient experienced loose stools on 25Dec2020, headache on 26Dec2020, achy muscles on 26Dec2020, sore arm on 20Dec2020, she thought maybe she had food poisoning bc of the weird symptoms on an unspecified date. She initially had a sore arm and the usual effects which she expected. Then, about six days into it she started having a headache and achy muscles. It all started with loose stool. She did get a COVID test because of signs of COVID. But it was negative. She thought maybe she had food poisoning bc of the weird symptoms. The headaches were bad, but they were not as bad currently. She had a loose stool that lasted a couple of days. The headaches were really mild currently. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 28Dec2020. Outcome of loose stools, sore arm was recovered in Dec2020, headache was recovering, achy muscles was not recovered, other was unknown.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: She thought maybe she had food poisoning bc of the weird symptoms; headache; achy muscles; loose stools; sore arm; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot # EH9899), on 20Dec2020 at single dose for covid-19 immunisation. Medical history included None. There were no concomitant medications. The patient experienced loose stools on 25Dec2020, headache on 26Dec2020, achy muscles on 26Dec2020, sore arm on 20Dec2020, she thought maybe she had food poisoning bc of the weird symptoms on an unspecified date. She initially had a sore arm and the usual effects which she expected. Then, about six days into it she started having a headache and achy muscles. It all started with loose stool. She did get a COVID test because of signs of COVID. But it was negative. She thought maybe she had food poisoning bc of the weird symptoms. The headaches were bad, but they were not as bad currently. She had a loose stool that lasted a couple of days. The headaches were really mild currently. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 28Dec2020. Outcome of loose stools, sore arm was recovered in Dec2020, headache was recovering, achy muscles was not recovered, other was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Pain, Vaccination site erythema
Clinical narrative: mild pain; an erythematous area on her left deltoid, it as a welt; This is a spontaneous report from a contactable physician reported for herself. This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient is an Emergency Room physician who received the vaccine on 17Dec2020 and had mild pain only for 36 hours after the injection. She never had any redness after her injection until day 12 she noticed an erythematous area on her left deltoid, it as a welt. The physician would like to know if she should get the 2nd dose of COVID-19 considering she had a delayed reaction to the first dose. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Inflammation, Local reaction, Tendonitis
Clinical narrative: severe local reaction; not just a strong bicep inflammation, but it extended out to the shoulder and the back of the neck; not just a strong bicep inflammation, but it extended out to the shoulder and the back of the neck; This is a spontaneous report from a non-contactable physician (patient).  This 39-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on unknown date at single dose for COVID-19 immunisation. The patient medical history and the concomitant medications were not reported. The patient experiencing a "severe local reaction" following the first dose of the vaccine. She described it as: not just a strong bicep inflammation, but it extended out to the shoulder and the back of the neck. The outcome was unknown.    No follow-up attempts are possible, information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Suspected COVID-19
Clinical narrative: potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose; potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose; This is a spontaneous report from a contactable Pharmacist. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were not reported. The pharmacist was questioning as to guidelines to the potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine and was isolated during the timing of the second dose. The outcome of the event was unknown.  Information on the Batch/Lot number has been requested.; Sender's Comments: The reported potential person infected with Sars-Cov-2 following the administration of the first dose of vaccine is considered ineffective of BNT162B2, and the Company cannot completely exclude the possible causality between the reported event and BNT162B2 administration.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Cardiac disorder, Chills, Decreased appetite, Fatigue
Clinical narrative: Headache; Fatigue; Muscle and joint pain; joint pain; Chills; heat surges; Sore throat; Not wanting to eat; Sore; Heart bothered me a little today; This is a spontaneous report from a contactable other Health Professional (Other HCP) (patient). A 35-year-old female Patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Ek9231) on 29Dec2020 10:30 AM, Intramuscularly, (vaccine location: Left arm) at single dose (first dose) for COVID-19 immunization. Medical history included Mitral valve prolapse (Mvp) and covid (patient had covid prior vaccination). Concomitant medication included naproxen a week before. Patient was allergic to Azithromycin. Patient received no other vaccine in four weeks. Patient experienced Headache, Fatigue, Muscle and joint pain, Chills and heat surges, Sore throat, Not wanting to eat, Sore, Heart bothered me a little today (29Dec2020 11:15). Patient did not receive any treatment. Patient did not have had covid tested post vaccination. The outcome of the events was unknown. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling hot, Headache, Myalgia, Oropharyngeal pain, Pain
Clinical narrative: Headache; Fatigue; Muscle and joint pain; joint pain; Chills; heat surges; Sore throat; Not wanting to eat; Sore; Heart bothered me a little today; This is a spontaneous report from a contactable other Health Professional (Other HCP) (patient). A 35-year-old female Patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Ek9231) on 29Dec2020 10:30 AM, Intramuscularly, (vaccine location: Left arm) at single dose (first dose) for COVID-19 immunization. Medical history included Mitral valve prolapse (Mvp) and covid (patient had covid prior vaccination). Concomitant medication included naproxen a week before. Patient was allergic to Azithromycin. Patient received no other vaccine in four weeks. Patient experienced Headache, Fatigue, Muscle and joint pain, Chills and heat surges, Sore throat, Not wanting to eat, Sore, Heart bothered me a little today (29Dec2020 11:15). Patient did not receive any treatment. Patient did not have had covid tested post vaccination. The outcome of the events was unknown. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Chills, Decreased appetite, Dyspnoea, Fatigue
Clinical narrative: Headache; Fatigue; Muscle and joint pain; joint pain; Chills; heat surges; Sore throat; Not wanting to eat; Sore; Heart bothered me a little today; This is a spontaneous report from a contactable other Health Professional (Other HCP) (patient). A 35-year-old female Patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Ek9231) on 29Dec2020 10:30 AM, Intramuscularly, (vaccine location: Left arm) at single dose (first dose) for COVID-19 immunization. Medical history included Mitral valve prolapse (Mvp) and covid (patient had covid prior vaccination). Concomitant medication included naproxen a week before. Patient was allergic to Azithromycin. Patient received no other vaccine in four weeks. Patient experienced Headache, Fatigue, Muscle and joint pain, Chills and heat surges, Sore throat, Not wanting to eat, Sore, Heart bothered me a little today (29Dec2020 11:15). Patient did not receive any treatment. Patient did not have had covid tested post vaccination. The outcome of the events was unknown. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Feeling abnormal, Feeling hot, Headache, Injection site pain, Myalgia
Clinical narrative: Headache; Fatigue; Muscle and joint pain; joint pain; Chills; heat surges; Sore throat; Not wanting to eat; Sore; Heart bothered me a little today; This is a spontaneous report from a contactable other Health Professional (Other HCP) (patient). A 35-year-old female Patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Ek9231) on 29Dec2020 10:30 AM, Intramuscularly, (vaccine location: Left arm) at single dose (first dose) for COVID-19 immunization. Medical history included Mitral valve prolapse (Mvp) and covid (patient had covid prior vaccination). Concomitant medication included naproxen a week before. Patient was allergic to Azithromycin. Patient received no other vaccine in four weeks. Patient experienced Headache, Fatigue, Muscle and joint pain, Chills and heat surges, Sore throat, Not wanting to eat, Sore, Heart bothered me a little today (29Dec2020 11:15). Patient did not receive any treatment. Patient did not have had covid tested post vaccination. The outcome of the events was unknown. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Oropharyngeal pain
Clinical narrative: Headache; Fatigue; Muscle and joint pain; joint pain; Chills; heat surges; Sore throat; Not wanting to eat; Sore; Heart bothered me a little today; This is a spontaneous report from a contactable other Health Professional (Other HCP) (patient). A 35-year-old female Patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Ek9231) on 29Dec2020 10:30 AM, Intramuscularly, (vaccine location: Left arm) at single dose (first dose) for COVID-19 immunization. Medical history included Mitral valve prolapse (Mvp) and covid (patient had covid prior vaccination). Concomitant medication included naproxen a week before. Patient was allergic to Azithromycin. Patient received no other vaccine in four weeks. Patient experienced Headache, Fatigue, Muscle and joint pain, Chills and heat surges, Sore throat, Not wanting to eat, Sore, Heart bothered me a little today (29Dec2020 11:15). Patient did not receive any treatment. Patient did not have had covid tested post vaccination. The outcome of the events was unknown. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.   No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 51.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Fatigue, Myalgia, Nausea, Pyrexia
Clinical narrative: felt tired, had terrible muscle pain, a headache, shivering, fever,  nausea (currently still  not feeling 100% and it's 3 days later)
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dizziness, Flushing
Clinical narrative: flushing; chest pressure; lightheadedness; This is a spontaneous report from a contactable nurse (patient). A 46-year-old female (not pregnant) patient received BNT162B2 (lot number EH 9899) first dose intramuscularly on right arm on 30Dec2020 09:30 AM at single dose for COVID-19 immunization. Medical history included HTN/GERD, allergies to pineapple and sulfa. Concomitant medications in two weeks included diltiazem (CARDIZEM), valsartan (DIOVAN), omeprazole (PROTONIX), meloxicam (MOBIC), docusate and bupropion hydrochloride (WELLBUTRIN). No other vaccine in four weeks. Patient experienced flushing, chest pressure and lightheadedness on 30Dec2020 09:30 AM, resulted in: Emergency room/department or urgent care and received treatment as ER evaluation. No COVID prior vaccination. No COVID tested post vaccination. The outcome of the events was recovered in Dec2020. The seriousness was reported as no.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain, Vaccination site pain
Clinical narrative: Headaches; body aches; Injection site pain; This is a spontaneous report from a contactable Pharmacist (patient). A 37-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on left arm on an unspecified date at single dose for COVID-19 immunization. The relevant medical history and concomitant medications were reported as none. The patient experienced headaches and body aches, injection site pain, on 29Dec2020 at 08:00 AM. The patient had Acetaminophen as the treatment for the events. The patient stated that no other vaccine in four weeks and no other medications in two weeks. No Covid prior vaccination and no Covid tested post vaccination. The outcome of the events was unknown.  Information about batch/lot number has been requested.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Chills, Fatigue, Pain, Pyrexia
Clinical narrative: received the vaccine on 12/16/20 - On 12/18/20, he developed a low-grade fever, chills, body aches, and felt fatigued
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Myalgia
Clinical narrative: Headache; Fatigue; Muscle/ joint pain; Muscle/ joint pain; This is a spontaneous report from a contactable physician (patient). A 40-year-old female patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) (lot number: Eh9899) Intramuscularly on 26Dec2020 10:30 AM (Anatomical Location: Arm Left) at single dose (first dose) for COVID-19 immunization. Medical history and concomitant medications were reported none. Patient did not have any allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient experienced Headache, Fatigue, Muscle/ joint pain on 26Dec2020 12:30 PM. Patient did not receive any treatment. The outcome of the events was recovered in unknown date. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Paraesthesia oral, Pruritus, Rash macular, Swelling
Clinical narrative: itching, swelling, hives redness, blotchy skin lips & tongue tingling, scratchy throat.  Began all upper body and spread to left leg.
Age: 27.0
Sex: F
Vaccine: COVID19
Symptoms: Throat irritation, Urticaria
Clinical narrative: itching, swelling, hives redness, blotchy skin lips & tongue tingling, scratchy throat.  Began all upper body and spread to left leg.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Investigation, Malaise
Clinical narrative: General Malaise; fatigue; light nausea; light headache; dizziness on and off; blotchy red itchy rash on neck, chest, sides, and back; blotchy red itchy rash on neck, chest, sides, and back; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on right arm on 29Dec2020 at 01:45 PM at single dose for COVID-19 immunization. The relevant medical history included asthma and COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19?: Yes). Concomitant medications included emtricitabine, tenofovir alafenamide fumarate (DESCOVY), fish oil, vitamin b complex, lisdexamfetamine mesilate (VYVANSE), cetirizine hydrochloride (ZYRTEC), all from Dec2020. The patient experienced general malaise, fatigue, light nausea, light headache, dizziness on and off, several hours later blotchy red itchy rash on neck, chest, sides, and back, lasted for 3-4 hours, all on 29Dec2020 at 07:00 PM. The patient had the most recent COVID-19 vaccine administered at nursing home/senior living facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive treatment for the events. The patient had nasal swab test with unknown results on 30Dec2020. The outcome of the events was recovered with sequel.  Information on the lot/batch number has been requested.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Rash macular, Rash pruritic
Clinical narrative: General Malaise; fatigue; light nausea; light headache; dizziness on and off; blotchy red itchy rash on neck, chest, sides, and back; blotchy red itchy rash on neck, chest, sides, and back; This is a spontaneous report from a contactable other healthcare professional (HCP) (patient). A 25-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscularly on right arm on 29Dec2020 at 01:45 PM at single dose for COVID-19 immunization. The relevant medical history included asthma and COVID-19 (Prior to vaccination, was the patient diagnosed with COVID-19?: Yes). Concomitant medications included emtricitabine, tenofovir alafenamide fumarate (DESCOVY), fish oil, vitamin b complex, lisdexamfetamine mesilate (VYVANSE), cetirizine hydrochloride (ZYRTEC), all from Dec2020. The patient experienced general malaise, fatigue, light nausea, light headache, dizziness on and off, several hours later blotchy red itchy rash on neck, chest, sides, and back, lasted for 3-4 hours, all on 29Dec2020 at 07:00 PM. The patient had the most recent COVID-19 vaccine administered at nursing home/senior living facility. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient did not receive treatment for the events. The patient had nasal swab test with unknown results on 30Dec2020. The outcome of the events was recovered with sequel.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Paraesthesia oral
Clinical narrative: Numbness and tingling (similar to a pins and needles sensation when a limb fall asleep) in my left hand/fingers and the left side on my lip; Numbness and tingling (similar to a pins and needles sensation when a limb fall asleep) in my left hand/fingers and the left side on my lip; Numbness and tingling (similar to a pins and needles sensation when a limb fall asleep) in my left hand/fingers and the left side on my lip; Numbness and tingling (similar to a pins and needles sensation when a limb fall asleep) in my left hand/fingers and the left side on my lip; This is a spontaneous report from a contactable Nurse (patient). A 40-year-old female patient (no pregnant) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), (lot number: EK9231) on 23Dec2020 07:15 PM via unknown route of administration (vaccine location: Left arm), at single dose (first dose) for COVID-19 immunization. Medical history was reported none. Concomitant medications included ibuprofen. There were no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient did not use other vaccine in four weeks. Patient experienced Numbness and tingling (similar to a pins and needles sensation when a limb fall asleep) in her left hand/fingers and the left side on her lip on 25Dec2020. Patient did not receive any treatment. The outcome of the events was not recovered. This case was assessed non-serious by reporter. The events did not result in death, Life threatening, Caused/prolonged hospitalization, Disabling/Incapacitating, Congenital anomaly/birth defect.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Dizziness, Ear infection, Headache, Injection site erythema
Clinical narrative: Administration of vaccine was given about 3 inches too low, not sure if it went into muscle or subcutaneous but I did end up with an injection site reaction 2 days later to include a 2x3 inch red, itchy, raised, hot to the touch welt.  Also had extreme dizziness, nausea, headache 2 days after injection.  Dizziness, nausea, headache subsided after 24hrs however injection site reaction will go away and come back randomly.  Seems to coincide with getting sick?  Was fine up until 12/29 when I did end up getting sick to include headache, body aches, chills.  I went to go get covid tested which was negative.  I ultimately had a sinus/ear infection.  However injection site reaction had gone away UNTIL I got sick on 12/29 then it showed up again and still have it as of today.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pruritus, Injection site reaction, Injection site recall reaction, Injection site swelling, Injection site urticaria
Clinical narrative: Administration of vaccine was given about 3 inches too low, not sure if it went into muscle or subcutaneous but I did end up with an injection site reaction 2 days later to include a 2x3 inch red, itchy, raised, hot to the touch welt.  Also had extreme dizziness, nausea, headache 2 days after injection.  Dizziness, nausea, headache subsided after 24hrs however injection site reaction will go away and come back randomly.  Seems to coincide with getting sick?  Was fine up until 12/29 when I did end up getting sick to include headache, body aches, chills.  I went to go get covid tested which was negative.  I ultimately had a sinus/ear infection.  However injection site reaction had gone away UNTIL I got sick on 12/29 then it showed up again and still have it as of today.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site warmth, Malaise, Nausea, Pain, Product administered at inappropriate site
Clinical narrative: Administration of vaccine was given about 3 inches too low, not sure if it went into muscle or subcutaneous but I did end up with an injection site reaction 2 days later to include a 2x3 inch red, itchy, raised, hot to the touch welt.  Also had extreme dizziness, nausea, headache 2 days after injection.  Dizziness, nausea, headache subsided after 24hrs however injection site reaction will go away and come back randomly.  Seems to coincide with getting sick?  Was fine up until 12/29 when I did end up getting sick to include headache, body aches, chills.  I went to go get covid tested which was negative.  I ultimately had a sinus/ear infection.  However injection site reaction had gone away UNTIL I got sick on 12/29 then it showed up again and still have it as of today.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test negative, Sinusitis
Clinical narrative: Administration of vaccine was given about 3 inches too low, not sure if it went into muscle or subcutaneous but I did end up with an injection site reaction 2 days later to include a 2x3 inch red, itchy, raised, hot to the touch welt.  Also had extreme dizziness, nausea, headache 2 days after injection.  Dizziness, nausea, headache subsided after 24hrs however injection site reaction will go away and come back randomly.  Seems to coincide with getting sick?  Was fine up until 12/29 when I did end up getting sick to include headache, body aches, chills.  I went to go get covid tested which was negative.  I ultimately had a sinus/ear infection.  However injection site reaction had gone away UNTIL I got sick on 12/29 then it showed up again and still have it as of today.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Musculoskeletal chest pain
Clinical narrative: costochondral soreness and pain, midsternal; left shoulder joint achiness; This is a spontaneous report from a contactable nurse (patient). A female patient of unspecified age received BNT162B2 on 19Dec2020 at single dose for COVID-19 immunization. Medical history and concomitant medications were not reported. Patient was having an unusual symptom. She cannot find this symptom in the clinical trials and would like to know if it occurred in the trials. She started having spontaneous costochondral soreness and pain, midsternal, on 27Dec2020, following left shoulder joint achiness on the 24Dec2020 through 26Dec2020. The outcome of the events was unknown.  Information on Lot/batch has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia
Clinical narrative: Headache; Muscle pain/ache; chills; This is a spontaneous report from a contactable Consumer (Patient's Girlfriend). A male patient of an unspecified age received the first dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine), via an unspecified route of administration on 18Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced headache, muscle pain/ache and chills in Dec2020 (pending for clarification). The reporter was looking for extended adverse events of headache, muscle pain/ache and chills information. Serious criteria was no. The outcome of the events was unknown.  Information on the Batch/Lot number has been requested.
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Injection site pain, Rash
Clinical narrative: Rash to face, fatigue, arm pain to injection site. Took Advil.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Vaccination site pain
Clinical narrative: slight fever; slight arm pain at vaccination site.; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 53 (units: unknown) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 29Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine yesterday. The patient took Tylenol due to slight fever on an unspecified date. She also reported having slight arm pain at vaccination site. Otherwise she reported feeling great. She would like to know if it was okay for her to take Tylenol. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Chills, Myalgia, Pain in extremity
Clinical narrative: slight fever; slight arm pain at vaccination site.; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 53 (units: unknown) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 29Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine yesterday. The patient took Tylenol due to slight fever on an unspecified date. She also reported having slight arm pain at vaccination site. Otherwise she reported feeling great. She would like to know if it was okay for her to take Tylenol. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: slight fever; slight arm pain at vaccination site.; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 53 (units: unknown) female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiry date: unknown) via an unspecified route of administration, on 29Dec2020, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the vaccine yesterday. The patient took Tylenol due to slight fever on an unspecified date. She also reported having slight arm pain at vaccination site. Otherwise she reported feeling great. She would like to know if it was okay for her to take Tylenol. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
Age: 22.0
Sex: F
Vaccine: COVID19
Symptoms: Cold sweat, Dizziness, Nausea
Clinical narrative: Dizziness; Nausea; Clammy; This is a spontaneous report from a contactable consumer (patient).  A 22-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number: not provided), via an unspecified route of administration on the left arm on 30Dec2020 10:30 at SINGLE DOSE for COVID-19 immunization. Medical history was none and there were no concomitant medications.  The patient stated that she got the vaccine at 10:30AM on 30Dec2020, and started to have a feeling of dizziness, nausea, and being clammy about 20 minutes after receiving the vaccine. The patient hasn't done any treatment for these yet. It was also mentioned that dizziness, nausea, and being clammy has pretty much gotten worse (not recovered).   Information on the batch/lot number has been requested.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site joint movement impairment, Vaccination site joint pain, Vaccination site movement impairment
Clinical narrative: Moderate joint pain and stiffness of left shoulder and upper arm (side where injection was given) requiring OTC pain med (Advil or Tylenol) starting 5 days after injection; Moderate joint pain and stiffness of left shoulder and upper arm (side where injection was given) requiring OTC pain med (Advil or Tylenol) starting 5 days after injection; Moderate joint pain and stiffness of left shoulder and upper arm (side where injection was given) requiring OTC pain med (Advil or Tylenol) starting 5 days after injection; This is a spontaneous report from a contactable nurse who reported for herself. A 58-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot #: EJ1685) via an unspecified route of administration on 22Dec2020 at 20:45 (at the age of 58-years-old) as a single dose in the left arm for COVID-19 immunization. Medical history included HTN (hypertension), hypothyroidism, and known allergies to PCN (penicillin), sulfa, losartan and lisinopril, all from unspecified dates and unspecified if ongoing. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications (taken within 2 weeks of vaccination) included levothyroxine sodium (SYNTHROID), HCTZ and fish oil, all taken for unspecified indications from unspecified dates. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Dec2020 at 09:00, the patient experienced "moderate joint pain and stiffness of left shoulder and upper arm (side where injection was given) requiring OTC (over the counter) pain med (Advil or Tylenol) starting 5 days after injection." It was reported that the event was non-serious and did not require hospitalization. The patient did not receive any treatment for the event (also reported that the patient required OTC pain medications for the event). The clinical outcome of the event "moderate joint pain and stiffness of left shoulder and upper arm (side where injection was given) requiring OTC pain med (Advil or Tylenol) starting 5 days after injection" was not recovered/not resolved. It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy on left axilla and elbow; This is a spontaneous report from a contactable nurse (patient). A 42-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 16Dec2020 at 11:45 (at the age of 42-years-old) as a single dose for Covid-19 vaccination. Medical history included cold urticaria and iritis from an unknown date. The patient did have allergies to the medications Sulpha, levaquin, cipro, and macrobid. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient's concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) for an unknown indications from unknown date. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Dec2020 at 08:00, the patient experienced Lymphadenopathy on left axilla and elbow. Therapeutic measures were not taken for the Lymphadenopathy on left axilla and elbow. The clinical outcome of the event Lymphadenopathy on left axilla and elbow was recovered on an unknown date in Dec2020.  Information on the lot/batch number has been requested.
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Headache for 18 hours; This is a spontaneous report from a contactable healthcare professional (patient). A 37-year-old male patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration on 28Dec2020 at 10:15 (at the age of 37-years-old) as a single dose in the left arm for COVID-19 vaccination. Medical history included hypertension from an unknown date. The patient did not have any allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. Concomitant medications were not reported. The patient did receive other vaccines within 4 weeks prior to vaccination (unspecified). On 28Dec2020 at 11:30, the patient experienced headache for 18 hours. Therapeutic measures were not given for the events. The clinical outcome of the event headache was recovered on an unknown date in Dec2020.    Information about batch/lot number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Headache, Malaise
Clinical narrative: Headache, anxiety, general feeling of unwellness
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: Lymphadenopathy; This is a spontaneous report from a contactable nurse (patient). A 30-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), via an unspecified route of administration in the left arm on 29Dec2020 at 13:45 (at the age of 30-years-old) as a single dose for Covid-19 vaccination. Medical history included hypertension from an unknown date. The patient was allergic to penicillin. The patient was not pregnant at the time of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient was not tested for COVID-19 post vaccination. The patient did receive other medications within 2 weeks of the vaccination (unspecified). The patient did not receive other vaccines within four weeks prior to the vaccination. On 30Dec2020 at 15:00, the patient experienced Lymphadenopathy. Therapeutic measures were not taken for the Lymphadenopathy. The clinical outcome of the event Lymphadenopathy was recovering.  Information on the lot/batch number has been requested.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash pruritic, Swelling
Clinical narrative: rash that began in my right arm and fingers and over the next week spread to my entire body including my face/ rash is very itchy; The rash is very itchy and swollen; This is a spontaneous report from a contactable nurse, who is also the patient.  A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: Fl0140), via an unspecified route of administration in the right arm on 17Dec2020 at 15:45 (at the age of 35-years-old) as a single dose for COVID-19 vaccination.  The patient had no relevant medical history. The patient had no known allergies. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications received within 2 weeks of the vaccination included bupropion hydrochloride (WELLBUTRIN XL) 175mg.  The patient had not received any other vaccine within 4 weeks prior to the vaccine.  On 23Dec2020 at 20:00 the patient broke out in a rash that began in the right arm and fingers and over the next week spread to the patient's entire body including the face. Per the patient the rash was very itchy and swollen. The patient visited an emergency room due to the events. The patient was treated for the events with oral OTC Benadryl and hydrocortisone cream, which the patient stated were not helping. The clinical outcome of the events itchy rash and swelling was not recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Injection site rash, Rash
Clinical narrative: rash that began in my right arm and fingers and over the next week spread to my entire body including my face/ rash is very itchy; The rash is very itchy and swollen; This is a spontaneous report from a contactable nurse, who is also the patient.  A 35-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: Fl0140), via an unspecified route of administration in the right arm on 17Dec2020 at 15:45 (at the age of 35-years-old) as a single dose for COVID-19 vaccination.  The patient had no relevant medical history. The patient had no known allergies. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications received within 2 weeks of the vaccination included bupropion hydrochloride (WELLBUTRIN XL) 175mg.  The patient had not received any other vaccine within 4 weeks prior to the vaccine.  On 23Dec2020 at 20:00 the patient broke out in a rash that began in the right arm and fingers and over the next week spread to the patient's entire body including the face. Per the patient the rash was very itchy and swollen. The patient visited an emergency room due to the events. The patient was treated for the events with oral OTC Benadryl and hydrocortisone cream, which the patient stated were not helping. The clinical outcome of the events itchy rash and swelling was not recovered.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Migraine, Nausea
Clinical narrative: Migraines for several days, nausea on day three; nausea; This is a spontaneous report from a contactable other healthcare professional, the patient.  A 51-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EL0140), via intramuscular route of administration in the left arm on 18Dec2020 at 09:00 (at the age of 51-years-old) as a single dose for COVID-19 vaccination.  Medical history included fibromyalgia and history of migraines. The patient did not have any known allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications were not reported; however, there were other medications the patient received within 2 weeks of the vaccination.  The patient had not received any other vaccine within 4 weeks prior to the vaccine.  On 21Dec2020 at 13:00 the patient experienced migraines for several days, nausea on day three. The patient did not receive any treatment for the events. The clinical outcome of the migraines for several days, nausea on day three was recovering.  It was also reported that since the vaccination, the patient had not been tested for COVID-19.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoaesthesia, Sensory disturbance
Clinical narrative: About a half hour after receiving the vaccine I started feeling a numbness under my right eye that progressed slowly progressed to around my right eye,  cheek, ear and upper right side of my teeth. I was able to move my muscles (no crooked smile) and close my eyes completely. Today I still have this strange feeling but it's very subtle.  This hasn't worsened at all since yesterday but hasn't gone away either.
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Fatigue and fever on day 5 after vaccination
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pallor, Presyncope, Tunnel vision
Clinical narrative: 12/29/2020 VACCINATION. WAS IN SITTING AREA, FELT FINE. AFTER 20  MINUTES, WALKED OUT OF ROOM AND FELT LIGHT HEADED AND DIZZY. NEAR SYNCOPY EPISODE, TUNNEL VISION, PALE.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Dizziness, Nausea, Palpitations
Clinical narrative: Sudden onset of tachycardia and palpitations; Sudden onset of tachycardia and palpitations; tachypnea without SOB; Sudden elevation of BP 178/100; Dizziness; Nausea; skin tingling; This is a spontaneous report from a contactable other healthcare professional, who is also the patient.  A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EJ1685), via an unspecified route of administration in the left arm on 30Dec2020 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 vaccination.  Medical history included Psoriasis, psoriatic arthritis, exercise induced asthma (no inhalers or treatment for >10 years). The patient had known allergies to methotrexate and chlorhexidine. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications received within 2 weeks of the vaccination included apremilast (OTEZLA) 30mg BID (twice a day), bupropion hydrochloride (WELLBUTRIN XL) 300 QD (once a day), and buspirone hydrochloride (BUSPAR) 5mg.  The patient had not received any other vaccine within 4 weeks prior to the vaccine.  On 30Dec2020 at 12:30 the patient experienced sudden onset of tachycardia and palpitations and tachypnea without SOB within 3-5 minutes of injection. The patient also had sudden elevation of BP 178/100, dizziness, nausea, and skin tingling. The patient's BP gradually came down over 60 minutes. The dizziness lasted about 50- 60 minutes. No medication or medical assistance required. The patient was able to drive home. The patient did not receive any treatment for the events. The clinical outcome of the events was recovered.  It was also reported that since the vaccination, the patient had been tested for COVID-19 on 27Dec2020, with Test: Nasal Swab and Result: Negative.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, SARS-CoV-2 test, Tachycardia, Tachypnoea
Clinical narrative: Sudden onset of tachycardia and palpitations; Sudden onset of tachycardia and palpitations; tachypnea without SOB; Sudden elevation of BP 178/100; Dizziness; Nausea; skin tingling; This is a spontaneous report from a contactable other healthcare professional, who is also the patient.  A 29-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Lot number: EJ1685), via an unspecified route of administration in the left arm on 30Dec2020 at 12:30 (at the age of 29-years-old) as a single dose for COVID-19 vaccination.  Medical history included Psoriasis, psoriatic arthritis, exercise induced asthma (no inhalers or treatment for >10 years). The patient had known allergies to methotrexate and chlorhexidine. The patient was not pregnant at the time of vaccination.  Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient's concomitant medications received within 2 weeks of the vaccination included apremilast (OTEZLA) 30mg BID (twice a day), bupropion hydrochloride (WELLBUTRIN XL) 300 QD (once a day), and buspirone hydrochloride (BUSPAR) 5mg.  The patient had not received any other vaccine within 4 weeks prior to the vaccine.  On 30Dec2020 at 12:30 the patient experienced sudden onset of tachycardia and palpitations and tachypnea without SOB within 3-5 minutes of injection. The patient also had sudden elevation of BP 178/100, dizziness, nausea, and skin tingling. The patient's BP gradually came down over 60 minutes. The dizziness lasted about 50- 60 minutes. No medication or medical assistance required. The patient was able to drive home. The patient did not receive any treatment for the events. The clinical outcome of the events was recovered.  It was also reported that since the vaccination, the patient had been tested for COVID-19 on 27Dec2020, with Test: Nasal Swab and Result: Negative.
Sex: U
Vaccine: COVID19
Symptoms: Heart rate, Oxygen saturation, Tachycardia
Clinical narrative: temporary tachycardia; This is a spontaneous report from a contactable physician. This physician reported similar events for 3 patients. This is 1st of 3 reports.   A patient of unspecified age and gender received the first dose of  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at single dose in Dec2019 for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient experienced temporary tachycardia after receiving the vaccine in Dec2019 with outcome of recovered.   The reporter monitored the patient using a pulse ox with a heart monitor. Let the patient drink water. She has monitored the patient for about 30 minutes and tachycardia has resolved in 30 to 40 minutes. The reporter was a bit concerned about what to expect and how to prepare for the patient's 2nd dose of the vaccine.  The information on the Lot / Batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2020520695 same reporter/event/product, different patient;US-PFIZER INC-2020517983 same reporter/event/product, different patient